| Year |
Citation |
Score |
| 2013 |
Alqudah MA, Agarwal S, Al-Keilani MS, Sibenaller ZA, Ryken TC, Assem M. NOTCH3 is a prognostic factor that promotes glioma cell proliferation, migration and invasion via activation of CCND1 and EGFR. Plos One. 8: e77299. PMID 24143218 DOI: 10.1371/Journal.Pone.0077299 |
0.735 |
|
| 2013 |
Agarwal S, Al-Keilani MS, Alqudah MA, Sibenaller ZA, Ryken TC, Assem M. Tumor derived mutations of protein tyrosine phosphatase receptor type k affect its function and alter sensitivity to chemotherapeutics in glioma. Plos One. 8: e62852. PMID 23696788 DOI: 10.1371/Journal.Pone.0062852 |
0.736 |
|
| 2013 |
Al-Keilani M, Agarwal S, Alqudah M, Sibenaller Z, Ryken T, Assem M. Abstract 2194: Tyrosyl DNA phosphodiesterase I is a prognostic factor and its inhibition synergizes response to topoisomerase poisons in malignant glioma. Cancer Research. 73: 2194-2194. DOI: 10.1158/1538-7445.Am2013-2194 |
0.712 |
|
| 2012 |
Assem M, Sibenaller Z, Agarwal S, Al-Keilani MS, Alqudah MA, Ryken TC. Enhancing diagnosis, prognosis, and therapeutic outcome prediction of gliomas using genomics. Omics : a Journal of Integrative Biology. 16: 113-22. PMID 22401657 DOI: 10.1089/Omi.2011.0031 |
0.724 |
|
| 2012 |
Agarwal S, Sibenaller Z, Ryken TC, Assem M. Abstract 2666: Receptor protein tyrosine phosphatase type kappa is a prognostic marker, essential for regulating malignant behavior of glioma cells Cancer Research. 72: 2666-2666. DOI: 10.1158/1538-7445.Am2012-2666 |
0.766 |
|
| 2010 |
Assem M, Sibenaller Z, Agarwal S, Al-Keilani M, Alqudah M, Marner J, Ryken TC. Abstract 1283: Chromosome 19 amplification and the consequent NOTCH and VEGF pathways over-activation are associated with malignant glioma poor outcome Cancer Research. 70: 1283-1283. DOI: 10.1158/1538-7445.Am10-1283 |
0.738 |
|
| 2009 |
Lin YS, Yasuda K, Assem M, Cline C, Barber J, Li CW, Kholodovych V, Ai N, Chen JD, Welsh WJ, Ekins S, Schuetz EG. The major human pregnane X receptor (PXR) splice variant, PXR.2, exhibits significantly diminished ligand-activated transcriptional regulation. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 37: 1295-304. PMID 19251824 DOI: 10.1124/Dmd.108.025213 |
0.323 |
|
| 2008 |
Pottier N, Yang W, Assem M, Panetta JC, Pei D, Paugh SW, Cheng C, Den Boer ML, Relling MV, Pieters R, Evans WE, Cheok MH. The SWI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemia. Journal of the National Cancer Institute. 100: 1792-803. PMID 19066270 DOI: 10.1093/Jnci/Djn416 |
0.389 |
|
| 2007 |
Pottier N, Cheok MH, Yang W, Assem M, Tracey L, Obenauer JC, Panetta JC, Relling MV, Evans WE. Expression of SMARCB1 modulates steroid sensitivity in human lymphoblastoid cells: identification of a promoter SNP that alters PARP1 binding and SMARCB1 expression. Human Molecular Genetics. 16: 2261-71. PMID 17616514 DOI: 10.1093/Hmg/Ddm178 |
0.368 |
|
| 2007 |
Marzolini C, Tirona RG, Gervasini G, Poonkuzhali B, Assem M, Lee W, Leake BF, Schuetz JD, Schuetz EG, Kim RB. A common polymorphism in the bile acid receptor farnesoid X receptor is associated with decreased hepatic target gene expression. Molecular Endocrinology (Baltimore, Md.). 21: 1769-80. PMID 17519356 DOI: 10.1210/Me.2007-0025 |
0.358 |
|
| 2007 |
Finkelstein D, Lamba V, Assem M, Rengelshausen J, Yasuda K, Strom S, Schuetz E. ADME transcriptome in Hispanic versus White donor livers: evidence of a globally enhanced NR1I3 (CAR, constitutive androstane receptor) gene signature in Hispanics. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 36: 989-1012. PMID 17118917 DOI: 10.1080/00498250600861769 |
0.304 |
|
| 2004 |
Lamba V, Yasuda K, Lamba JK, Assem M, Davila J, Strom S, Schuetz EG. PXR (NR1I2): splice variants in human tissues, including brain, and identification of neurosteroids and nicotine as PXR activators. Toxicology and Applied Pharmacology. 199: 251-65. PMID 15364541 DOI: 10.1016/J.Taap.2003.12.027 |
0.321 |
|
| 2004 |
Lamba JK, Lamba V, Yasuda K, Lin YS, Assem M, Thompson E, Strom S, Schuetz E. Expression of constitutive androstane receptor splice variants in human tissues and their functional consequences. The Journal of Pharmacology and Experimental Therapeutics. 311: 811-21. PMID 15194709 DOI: 10.1124/Jpet.104.069310 |
0.341 |
|
| 2002 |
Ecarnot-Laubriet A, Assem M, Poirson-Bichat F, Moisant M, Bernard C, Lecour S, Solary E, Rochette L, Teyssier J-. Stage-dependent activation of cell cycle and apoptosis mechanisms in the right ventricle by pressure overload. Biochimica Et Biophysica Acta. 1586: 233-242. PMID 11997075 DOI: 10.1016/S0925-4439(01)00101-6 |
0.322 |
|
| 2001 |
Laubriet A, Fantini E, Assem M, Cordelet C, Teyssier J, Athias P, Rochette L. Changes in HSP70 and P53 expression are related to the pattern of electromechanical alterations in rat cardiomyocytes during simulated ischemia. Molecular and Cellular Biochemistry. 220: 77-86. PMID 11451386 DOI: 10.1023/A:1010832731491 |
0.325 |
|
| 2001 |
Kuehl P, Zhang J, Lin Y, Lamba J, Assem M, Schuetz J, Watkins PB, Daly A, Wrighton SA, Hall SD, Maurel P, Relling M, Brimer C, Yasuda K, Venkataramanan R, et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nature Genetics. 27: 383-91. PMID 11279519 DOI: 10.1038/86882 |
0.309 |
|
| 1999 |
Martin L, Assem M, Piard F. Are there several types of colorectal carcinomas? Correlations with genetic data. European Journal of Cancer Prevention. 8. DOI: 10.1097/00008469-199912001-00003 |
0.326 |
|
| 1996 |
Garrido C, Mehlen P, Fromentin A, Hammann A, Assem M, Arrigo A, Chauffert B. Inconstant Association between 27‐kDa Heat‐Shock Protein (Hsp27) Content and Doxorubicin Resistance in Human Colon Cancer Cells Febs Journal. 237: 653-659. PMID 8647109 DOI: 10.1111/J.1432-1033.1996.0653P.X |
0.387 |
|
| 1995 |
Garrido C, Chauffert B, Pinard D, Tibaut F, Genne P, Assem M, Dimanche-Boitrel M. Circumvention of confluence‐dependent resistance in a human multi‐drug‐resistant colon‐cancer cell line International Journal of Cancer. 61: 873-879. PMID 7790124 DOI: 10.1002/Ijc.2910610621 |
0.362 |
|
| 1994 |
Assem M, Bonvalot S, Beltramo JL, Garrido C, Dimanche-Boitrel MT, Genne P, Rebibou JM, Caillot D, Chauffert B. Deleterious effect of serum proteins on the amphotericin B-induced potentiation of cisplatin in human colon cancer cells. British Journal of Cancer. 70: 631-635. PMID 7917908 DOI: 10.1038/Bjc.1994.362 |
0.342 |
|
| Show low-probability matches. |